Literature DB >> 24389259

Maintaining the reproductive potential of cancer patients during cancer treatment.

Djana Harp1, Indrajit Chowdhury1, Minerva Garcia-Barrio2, Crystal Welch1, Roland Matthews1, Winston Thompson1.   

Abstract

Cancer therapies are known to alter the reproductive potential in cancer patients. Due to improved survival rates in cancer patients of reproductive age, considerations of the long-term effects of cancer therapy have become more significant. Oncofertility is a new discipline in medicine that deals with maintaining the reproductive potential of cancer patients while they are receiving gonadotoxic cancer treatment. The purpose of this review is to explore how cancer treatment impairs reproductive functioning and present the current options for preservation of fertility in women. All patients with reproductive potential should be made aware of the possible treatment-related infertility and be offered appropriate fertility preservation options before cancer treatment is instituted. The hope is that, in the future, mechanism(s) can be developed to preserve immature germ cells in the ovary, so that they can be used for fertilization in vivo or in vitro.

Entities:  

Mesh:

Year:  2014        PMID: 24389259      PMCID: PMC6178803          DOI: 10.2741/s412

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  85 in total

Review 1.  Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women.

Authors:  Hengxi Chen; Jinke Li; Tao Cui; Lina Hu
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma.

Authors:  Alessandra Longhi; Elettra Pignotti; Michela Versari; Susanna Asta; Gaetano Bacci
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

Review 3.  The role of gonadotropins in the follicular phase.

Authors:  Ioannis E Messinis; Christina I Messini; Konstantinos Dafopoulos
Journal:  Ann N Y Acad Sci       Date:  2010-09       Impact factor: 5.691

4.  Effects of follicle-stimulating hormone and serum substitution on the in-vitro growth of human ovarian follicles.

Authors:  C S Wright; O Hovatta; R Margara; G Trew; R M Winston; S Franks; K Hardy
Journal:  Hum Reprod       Date:  1999-06       Impact factor: 6.918

Review 5.  The effects of radiotherapy and chemotherapy on female reproduction.

Authors:  D Meirow; D Nugent
Journal:  Hum Reprod Update       Date:  2001 Nov-Dec       Impact factor: 15.610

6.  Chromosome cohesion decreases in human eggs with advanced maternal age.

Authors:  Francesca E Duncan; Jessica E Hornick; Michael A Lampson; Richard M Schultz; Lonnie D Shea; Teresa K Woodruff
Journal:  Aging Cell       Date:  2012-08-27       Impact factor: 9.304

7.  Predicting age of ovarian failure after radiation to a field that includes the ovaries.

Authors:  W Hamish B Wallace; Angela B Thomson; Frank Saran; Tom W Kelsey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

8.  Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary.

Authors:  Jung-Hye Choi; C Blake Gilks; Nelly Auersperg; Peter C K Leung
Journal:  J Clin Endocrinol Metab       Date:  2006-09-05       Impact factor: 5.958

Review 9.  Hormonal suppression for fertility preservation in males and females.

Authors:  Marvin L Meistrich; Gunapala Shetty
Journal:  Reproduction       Date:  2008-05-30       Impact factor: 3.906

10.  Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer.

Authors:  Richard A Anderson; David A Cameron
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.